Basic Information
Basic information for NR2F1-AS1-223-46aa
Peptide Name NR2F1-AS1-223-46aa
Genome Position chr5:93538378-93538515[-]
Species Human
Peptide Sequence MSSRQIGLGVRYSSYQKGKLGFFTSPRIWHDSSPLSCQLSALSDCI
Peptide Length 46
Unique No (NR2F1-AS1-202-46aa,NR2F1-AS1-209-46aa,NR2F1-AS1-244-46aa,NR2F1-AS1-246-46aa,NR2F1-AS1-265-46aa,NR2F1-AS1-269-46aa,NR2F1-AS1-271-46aa)
Grand Average of Hydropathicity -0.1739
Relative Molecular Mass 5919.5
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000653643;NR2F1-AS1-223
Transcript Length 8117
Coding Ability 0.316
DNA Sequence Corresponding to Peptide ATGTCCTCAAGGCAAATTGGCTTAGGTGTTCGATATTCTTCTTACCAGAAAGGTAAACTTGGGTTTTTTACTTCACCCAGGATTTGGCATGACAGTTCCCCATTATCTTGTCAGCTTAGTGCTTTAAGTGATTGCATT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :